Showing results (131-140 of 159) with videos related to

Sort By:
Pageof 16
Cell|July 11, 2008
Exported proteins required for virulence and rigidity of Plasmodium falciparum-infected human erythrocytesAlexander G Maier, Melanie Rug, Matthew T O'Neill, et al.
Malaria Journal|December 1, 2016
Characterizing the impact of sustained sulfadoxine/pyrimethamine use upon the Plasmodium falciparum population in MalawiMatt Ravenhall, Ernest Diez Benavente, Mwapatsa Mipando, et al.
Plos One|June 17, 2014
Underpinning sustainable vector control through informed insecticide resistance managementEdward K Thomsen, Clare Strode, Kay Hemmings, et al.
Medrxiv : the Preprint Server for Health Sciences|August 14, 2023
LLIN Evaluation in Uganda Project (LLINEUP) - <i>Plasmodium</i> infection prevalence and genotypic markers of insecticide resistance in <i>Anopheles</i> vectors from 48 districts of UgandaAmy Lynd, Samuel Gonahasa, Sarah G Staedke, et al.
Parasites & Vectors|April 6, 2012
A global map of dominant malaria vectorsMarianne E Sinka, Michael J Bangs, Sylvie Manguin, et al.
Scientific Reports|June 24, 2024
LLIN Evaluation in Uganda Project (LLINEUP)-effects of a vector control trial on Plasmodium infection prevalence and genotypic markers of insecticide resistance in Anopheles vectors from 48 districts of UgandaAmy Lynd, Samuel Gonahasa, Sarah G Staedke, et al.
Emerging Infectious Diseases|April 19, 2016
An Operational Framework for Insecticide Resistance Management PlanningEmmanuel Chanda, Edward K Thomsen, Mulenga Musapa, et al.
Plos Neglected Tropical Diseases|October 16, 2009
Recent rapid rise of a permethrin knock down resistance allele in Aedes aegypti in MéxicoGustavo Ponce García, Adriana E Flores, Ildefonso Fernández-Salas, et al.
Parasites & Vectors|December 7, 2010
The dominant Anopheles vectors of human malaria in Africa, Europe and the Middle East: occurrence data, distribution maps and bionomic précisMarianne E Sinka, Michael J Bangs, Sylvie Manguin, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 30, 2018
Targeting the IL33-NLRP3 axis improves therapy for experimental cerebral malariaPatrick Strangward, Michael J Haley, Manuel G Albornoz, et al.
Pageof 16